Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-012336

President & CEO sold 108,882 shares at an average $42.19 ($4,594,176)

  • President & CEO acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2019-02-19 Option exercise +33,333 $7.21 $240,331 350,924 D
ROBIN HOWARD W President & CEO 2019-02-19 Sale −33,333 $42.32 $1,410,653 317,591 D
ROBIN HOWARD W President & CEO 2019-02-19 Sale −8,882 $42.39 $376,508 308,709 D
ROBIN HOWARD W President & CEO 2019-02-20 Option exercise +33,334 $7.21 $240,338 342,043 D
ROBIN HOWARD W President & CEO 2019-02-20 Sale −33,334 $43.20 $1,440,029 308,709 D
ROBIN HOWARD W President & CEO 2019-02-21 Option exercise +33,333 $7.21 $240,331 342,042 D
ROBIN HOWARD W President & CEO 2019-02-21 Sale −33,333 $41.01 $1,366,986 308,709 D
Derivatives
ROBIN HOWARD W President & CEO 2019-02-19 Option exercise · Common Stock −33,333 166,667 D
ROBIN HOWARD W President & CEO 2019-02-20 Option exercise · Common Stock −33,334 133,333 D
ROBIN HOWARD W President & CEO 2019-02-21 Option exercise · Common Stock −33,333 100,000 D
Open-market sales · 108,882 sh · avg $42.19 · $4,594,176
Loading xslF345X03/doc4.xml…